Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Incyte Corporation
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Currently enrolled and receiving treatment in an Incyte-sponsored itacitinib (INCB39110)-based clinical study (parent Protocol).
Currently tolerating treatment as defined by the parent Protocol.
Currently receiving clinical benefit from itacitinib-based treatment, as determined by the investigator.
Has demonstrated compliance, as assessed by the investigator, with the parent protocol requirements.
Willingness and ability to comply with scheduled visits, treatment plans, and any other study procedures indicated in this Protocol.
Willingness to avoid pregnancy or fathering children..
Ability to comprehend and willingness to sign an ICF.
You may not be if
Able to access itacitinib therapy commercially.
Participants with an uncontrolled intercurrent illness or any concurrent condition that, in the investigator's opinion, would jeopardize the safety of the participant or compliance with the Protocol.
